Linked Life Data

12431817

Source:http://linkedlifedata.com/resource/pubmed/id/12431817

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12431817rdf:typepubmed:Citationlld:pubmed
pubmed-article:12431817lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:12431817lifeskim:mentionsumls-concept:C0021760lld:lifeskim
pubmed-article:12431817lifeskim:mentionsumls-concept:C1516170lld:lifeskim
pubmed-article:12431817lifeskim:mentionsumls-concept:C1148774lld:lifeskim
pubmed-article:12431817lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:12431817pubmed:dateCreated2002-11-14lld:pubmed
pubmed-article:12431817pubmed:abstractTextInterleukin-6 (IL-6) is a multifunctional cytokine which is involved in regulation of growth of various malignant tumors. IL-6 binds to its receptor, which is composed of a ligand-binding and a signal-transducing subunit and activates pathways of signal transducers and activators of transcription and mitogen-activated protein kinases (MAPKs). In prostate cancer cells, IL-6 induces divergent proliferative responses. Serum levels of IL-6 are elevated in patients with therapy-resistant carcinoma of the prostate. We have investigated whether IL-6 interacts with the androgen signaling pathway in prostate cancer cells. In DU-145 cells, transiently transfected with androgen receptor (AR) cDNA, IL-6 caused ligand-independent and synergistic activation of the AR. Nonsteroidal antagonists of the AR down-regulated AR activity induced by IL-6. In LNCaP cells, IL-6-induced expression of the AR-regulated prostate-specific antigen gene. Inhibitors of protein kinase A and C and MAPK down-regulated IL-6-induced AR activity. IL-6 expression in human prostate tissue was studied by immunohistochemistry. In benign prostatic tissue, IL-6 immunoreactivity was confined to basal cells. In prostate intraepithelial neoplasia and in cancer tissue, atypical intraluminal and cancer cells expressed IL-6. The expression of IL-6 receptor was demonstrated in benign and malignant tissue in both epithelium and stroma. In the authors' laboratory, IL-6-inhibited proliferation of parental LNCaP cells. A new LNCaP subline was generated to investigate changes in signal transduction which might occur after prolonged treatment with IL-6. In the subline LNCaP-IL-6+, IL-6 neither reduced a number of cells nor caused G1 growth arrest. IL-6 receptor expression declined during long-term IL-6 treatment. However, IL-6-up-regulated AR expression and was capable of inducing AR activity in LNCaP-IL-6+ cells. Parental LNCaP cells do not express IL-6. In contrast, IL-6 mRNA and protein expression were detectable in high passages of LNCaP-IL-6+ cells. Thus changes in signal transduction occur in prostate cancer cells after prolonged IL-6 treatmentlld:pubmed
pubmed-article:12431817pubmed:languageenglld:pubmed
pubmed-article:12431817pubmed:citationSubsetIMlld:pubmed
pubmed-article:12431817pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12431817pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12431817pubmed:statusMEDLINElld:pubmed
pubmed-article:12431817pubmed:authorpubmed-author:BartschGeorgGlld:pubmed
pubmed-article:12431817pubmed:authorpubmed-author:HobischAlfred...lld:pubmed
pubmed-article:12431817pubmed:authorpubmed-author:CuligZoranZlld:pubmed
pubmed-article:12431817pubmed:ownerNLMlld:pubmed
pubmed-article:12431817pubmed:authorsCompleteYlld:pubmed
pubmed-article:12431817pubmed:pagination231-8lld:pubmed
pubmed-article:12431817pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12431817pubmed:articleTitleInterleukin-6 regulates androgen receptor activity and prostate cancer cell growth.lld:pubmed
pubmed-article:12431817pubmed:affiliationDepartment of Urology, University of Innsbruck, A-6020 Innsbruck, Austria. zoran.culig@uibk.ac.atlld:pubmed
entrez-gene:3569entrezgene:pubmedpubmed-article:12431817lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12431817lld:entrezgene
lhgdn:association:7947lhgdn:found_inpubmed-article:12431817lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12431817lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12431817lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12431817lld:pubmed